University of Glasgow
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 1451-01-07
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.gla.ac.uk
Doxorubicin in Treating Women With Advanced Breast Cancer
Phase 2
- Conditions
- First Posted Date
- 2004-04-30
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- University of Glasgow
- Target Recruit Count
- 25
- Registration Number
- NCT00003165
- Locations
- π¬π§
Cancer Research Campaign Clinical Trials Unit-Birmingham (CRCTU), Birmingham, England, United Kingdom
π¬π§Weston Park Hospital, Sheffield, England, United Kingdom
π¬π§Western General Hospital, Edinburgh, Scotland, United Kingdom
Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-05-08
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- University of Glasgow
- Registration Number
- NCT00004008
- Locations
- π¬π§
Royal Infirmary, Glasgow, Scotland, United Kingdom
π¬π§Christie Hospital N.H.S. Trust, Manchester, England, United Kingdom
π¬π§Weston Park Hospital, Sheffield, England, United Kingdom
Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma
Phase 3
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- University of Glasgow
- Target Recruit Count
- 44
- Registration Number
- NCT00006231
- Locations
- π¬π§
Gartnavel General Hospitall, Glasgow, Scotland, United Kingdom
π¬π§West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom
π¬π§Stobhill General Hospital, Glasgow, Scotland, United Kingdom
Β© Copyright 2024. All Rights Reserved by MedPath